Diovan, Valsartan Newswire
Comprehensive Real-Time News Feed for Diovan, Valsartan (generic).
Results 1 - 5 of 5 in Diovan, Valsartan (generic)
GBI Research, the leading business intelligence provider, has released its latest research: 'Anti-Hypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries ', which provides in-depth analysis of hypertension therapeutics market within the eight major geographies of the US, the top five European countries , Japan and Canada. The report provides an estimation of market size for 2013, along with market forecast until 2020. Comment?
Taking prescriptions as directed is so important to maintaining your heart health. We know this is becoming more and more difficult for people to do given the rising costs of these medications. Comment?
The CHMP is EU's review body, something like the FDA's Advisory Committee, but one that the EMA listens to more closely than does the FDA to its AdComm. The CHMP has recommended Entresto, the heart failure drug of Novartis , for approval in the EU. Comment?
Given the large, almost completely de-risked late-stage pipeline, the company is heavily undervalued at $150 million net of cash. Every time Theravance Biopharma reports earnings, I feel like Scrooge McDuck in his money bin for the incredible value this stock offers. Comment?
Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles. Comment?
- « Previous
- Next »
Copyright © 2016 Topix LLC